Doesnt matter what the company thinks the outlook is... its what is the sector outlook... an that for the time is squeezed margins and increasing competition
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025